Camp4 Therapeutics (CAMP) Payables (2023 - 2026)

Camp4 Therapeutics has reported Payables for 4 years, with the latest figure at $863000.0 in Q1 2026.

• Quarterly Payables changed N/A year-over-year to $863000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $863000.0 (changed N/A YoY) and the FY2025 annual result came in at $182000.0, down 84.96% from the prior year.
• Payables advanced to $863000.0 in Q1 2026 per CAMP's latest filing, from $182000.0 in the prior quarter.
• Over five years, Payables peaked at $3.9 million in Q3 2024 and troughed at $182000.0 in Q4 2025.
• A 4-year average of $1.3 million and a median of $1.0 million in 2023 frame the typical range for Payables.
• The sharpest annual moves came in 2024 and 2025: Payables climbed 16.12% in 2024, then tumbled 84.96% in 2025.
• Over 4 years, Payables stood at $1.0 million in 2023, then advanced by 16.12% to $1.2 million in 2024, then sank by 84.96% to $182000.0 in 2025, then jumped by 374.18% to $863000.0 in 2026.
• According to Business Quant data, Payables over the past three periods registered $863000.0, $182000.0, and $585000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.